Does Rigel (RIGL) Have the Potential to Rally 40.88% as Wall Street Analysts Expect?
Portfolio Pulse from
Analysts have set a mean price target for Rigel Pharmaceuticals (RIGL) that suggests a potential 40.9% upside. Despite the historical unreliability of price targets, the consensus among analysts in raising earnings estimates indicates a positive outlook for the stock.
February 03, 2025 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Rigel Pharmaceuticals (RIGL) has a mean price target indicating a 40.9% upside. Analysts' consensus in raising earnings estimates suggests a positive outlook for the stock.
The mean price target for RIGL suggests a significant upside, and the strong agreement among analysts in raising earnings estimates supports this potential. This combination of factors indicates a likely positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100